NCT00002108View on ClinicalTrials.gov

3TC (Lamivudine; GR109714X) Open-Label Program

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Lamivudine

DRUG

Zidovudine

Trial Locations (1)

07960

Kern - McNeill International, Morristown

Sponsors

Lead Sponsor

Glaxo Wellcome
All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002108 - 3TC (Lamivudine; GR109714X) Open-Label Program | Biotech Hunter | Biotech Hunter